Millions use drugs like Ozempic globally and its affecting the economy | The Business

Hundreds of millions of people are predicted to be using weight loss medications globally over the next decade, which could lead to an uptick in productivity. The uptake in Australia has been slower than in the US, but one fitness business owner says she's already feeling the impact of fewer clients. The active ingredient in most weight loss drugs — including Mounjaro, Wegovy and Ozempic — mimics a hormone called glucagon-like peptide-1 (GLP-1). That peptide slows digestion and sends fullness signals to the brain, resulting in people eating less. The growing popularity of GLP-1 medications is doing more than transforming waistlines. Adam Spielman, head of future health at Citigroup, co-authored a report looking at the reach of GLP-1 medications in the US and possible future commercial implications and is "absolutely convinced" GLP-1s would have "a really profound effect on the Australian economy", especially after 2031 when patents for the drugs end, allowing more competitors to enter the market. He says the impact on the food industrye would be uneven, with fruit and vegetable growers among those likely to profit, while McDonald's or Burger King, could see the opposite. #ABCBusiness Subscribe: Read more here: ABC News provides around the clock coverage of news events as they break in Australia and abroad. It's news when you want it, from Australia's most trusted news organisation. For more from ABC News, click here: Watch more ABC News content ad-free on ABC iview: Go deeper on our ABC News In-depth channel: Like ABC News on Facebook: Follow ABC News on Instagram: Follow ABC News on X (Twitter): Note: In most cases, our captions are auto-generated. #ABCNews #ABCNewsAustralia #optiplex keto gummies reviews #bio life keto gummies reviews #diet pills banned in usa